Cansortium(US OTC: CNTMF: $0.77):Q3 EBITDA Outperformance Despite FL Pricing Pressure; Remains on Track to Scale CapacityCansortium reported Q3/21 results of $16M in revenues and $4.9M adjusted EBITDA. Revenues came in modestly below our forecastof $18M while adjusted EBITDA exceeded our estimate of $3.9M on higher than anticipated gross margins on achieved operational efficiencies
